T-ALL was considered as either prothymocyte- (expressing CD7), early thymocyte- (expressing CD5, CD2, and CD1), intermediate thymocyte- (CD1, CD4, or CD8), or mature thymocyte-like (CD3 and TCR surface expressed). This evidence concerns the gene CD8A and acute lymphoblastic leukemia.